Genesee Capital Advisors, LLC Axogen, Inc. Transaction History

Genesee Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$17.8 - $23.5 $2.01 Million - $2.65 Million	-112,867 Closed	0 $0
Q1 2021 Apr 16, 2021	SELL	$17.18 - $22.6 $612,965 - $806,345	-35,679 Reduced 24.02%	112,867 $2.29 Million
Q4 2020 Jan 19, 2021	SELL	$11.5 - $17.96 $4,220 - $6,591	-367 Reduced 0.25%	148,546 $2.66 Million
Q3 2020 Oct 29, 2020	BUY	$10.62 - $13.12 $1.58 Million - $1.95 Million	148,913 New	148,913 $1.73 Million

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $628M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.